The higher iron levels in AD patients will stimulate the expression of amyloid protein precursor (APP) gene and tan protein, which leads to binding to Aβ and tau protein, further promoting Aβ aggregation and tau hyperphosphorylation.12 This evidence concerns the gene MAPT and Alzheimer disease.